Barclays’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $77.7M | Buy |
278,835
+254,341
| +1,038% | +$73.2M | 0.03% | 580 |
|
|
2025
Q4 | $7.42M | Sell |
24,494
-8,172
| -25% | -$2.55M | ﹤0.01% | 1914 |
|
|
2025
Q3 | $9.16M | Buy |
32,666
+12,818
| +65% | +$3.49M | ﹤0.01% | 1728 |
|
|
2025
Q2 | $4.79M | Sell |
19,848
-10,001
| -34% | -$2.36M | ﹤0.01% | 2172 |
|
|
2025
Q1 | $7.27M | Sell |
29,849
-10,570
| -26% | -$3.18M | ﹤0.01% | 1632 |
|
|
2024
Q4 | $13.3M | Sell |
40,419
-1,557
| -4% | -$528K | 0.01% | 1363 |
|
|
2024
Q3 | $14M | Sell |
41,976
-5,406
| -11% | -$1.72M | 0.01% | 1253 |
|
|
2024
Q2 | $12.9M | Buy |
47,382
+7,528
| +19% | +$2.19M | 0.01% | 1088 |
|
|
2024
Q1 | $13.8M | Sell |
39,854
-22,098
| -36% | -$7.27M | 0.01% | 1194 |
|
|
2023
Q4 | $20M | Buy |
61,952
+16,747
| +37% | +$5.25M | 0.01% | 1049 |
|
|
2023
Q3 | $16.2M | Buy |
45,205
+1,245
| +3% | +$480K | 0.01% | 823 |
|
|
2023
Q2 | $16.7M | Buy |
43,960
+20,554
| +88% | +$8.36M | 0.01% | 789 |
|
|
2023
Q1 | $11.2M | Sell |
23,406
-42,996
| -65% | -$20.1M | 0.01% | 1111 |
|
|
2022
Q4 | $27.9M | Buy |
66,402
+12,293
| +23% | +$4.96M | 0.02% | 730 |
|
|
2022
Q3 | $22.6M | Buy |
54,109
+30,863
| +133% | +$15.4M | 0.03% | 563 |
|
|
2022
Q2 | $11.5M | Sell |
23,246
-4,628
| -17% | -$2.41M | 0.01% | 956 |
|
|
2022
Q1 | $15.7M | Sell |
27,874
-8,911
| -24% | -$5.37M | 0.01% | 765 |
|
|
2021
Q4 | $27.8M | Sell |
36,785
-8,878
| -19% | -$6.64M | 0.02% | 809 |
|
|
2021
Q3 | $34.1M | Buy |
45,663
+12,847
| +39% | +$9.62M | 0.02% | 676 |
|
|
2021
Q2 | $21.1M | Buy |
32,816
+509
| +2% | +$310K | 0.02% | 873 |
|
|
2021
Q1 | $18.5M | Buy |
32,307
+11,397
| +55% | +$6.75M | 0.02% | 830 |
|
|
2020
Q4 | $12.2M | Sell |
20,910
-40
| -0.2% | -$22.8K | 0.01% | 1076 |
|
|
2020
Q3 | $10.8M | Buy |
20,950
+419
| +2% | +$212K | 0.01% | 1003 |
|
|
2020
Q2 | $9.27M | Sell |
20,531
-6,354
| -24% | -$2.8M | 0.02% | 1010 |
|
|
2020
Q1 | $9.43M | Buy |
26,885
+353
| +1% | +$130K | 0.02% | 1020 |
|
|
2019
Q4 | $9.82M | Sell |
26,532
-8,193
| -24% | -$2.89M | 0.01% | 1417 |
|
|
2019
Q3 | $11.6M | Buy |
34,725
+3,528
| +11% | +$1.15M | 0.01% | 1197 |
|
|
2019
Q2 | $9.75M | Buy |
31,197
+26,508
| +565% | +$7.94M | 0.01% | 1370 |
|
|
2019
Q1 | $1.43M | Sell |
4,689
-42,017
| -90% | -$11.3M | ﹤0.01% | 2993 |
|
|
2018
Q4 | $10.8M | Buy |
46,706
+39,653
| +562% | +$10.6M | 0.02% | 1105 |
|
|
2018
Q3 | $2.21M | Buy |
7,053
+2,784
| +65% | +$864K | ﹤0.01% | 2760 |
|
|
2018
Q2 | $1.23M | Sell |
4,269
-1,216
| -22% | -$336K | ﹤0.01% | 3058 |
|
|
2018
Q1 | $1.37M | Sell |
5,485
-2,052
| -27% | -$522K | ﹤0.01% | 2849 |
|
|
2017
Q4 | $1.8M | Buy |
7,537
+6,157
| +446% | +$1.49M | ﹤0.01% | 2535 |
|
|
2017
Q3 | $307K | Sell |
1,380
-2,917
| -68% | -$656K | ﹤0.01% | 4051 |
|
|
2017
Q2 | $972K | Buy |
4,297
+56
| +1% | +$12.2K | ﹤0.01% | 2918 |
|
|
2017
Q1 | $846K | Buy |
4,241
+3,321
| +361% | +$640K | ﹤0.01% | 2879 |
|
|
2016
Q4 | $168K | Buy |
920
+370
| +67% | +$63.1K | ﹤0.01% | 4351 |
|
|
2016
Q3 | $91K | Sell |
550
-502
| -48% | -$76.2K | ﹤0.01% | 4569 |
|
|
2016
Q2 | $149K | Buy |
1,052
+384
| +57% | +$54.8K | ﹤0.01% | 4133 |
|
|
2016
Q1 | $91K | Buy |
668
+54
| +9% | +$7.09K | ﹤0.01% | 4410 |
|
|
2015
Q4 | $85K | Buy |
614
+39
| +7% | +$5.41K | ﹤0.01% | 4502 |
|
|
2015
Q3 | $77K | Sell |
575
-108
| -16% | -$15.5K | ﹤0.01% | 4779 |
|
|
2015
Q2 | $103K | Sell |
683
-3,396
| -83% | -$486K | ﹤0.01% | 4646 |
|
|
2015
Q1 | $551K | Buy |
4,079
+446
| +12% | +$55.3K | ﹤0.01% | 3537 |
|
|
2014
Q4 | $435K | Sell |
3,633
-933
| -20% | -$107K | ﹤0.01% | 4001 |
|
|
2014
Q3 | $516K | Sell |
4,566
-1,181
| -21% | -$140K | ﹤0.01% | 3921 |
|
|
2014
Q2 | $684K | Sell |
5,747
-4,906
| -46% | -$599K | ﹤0.01% | 3685 |
|
|
2014
Q1 | $1.36M | Buy |
10,653
+2,025
| +23% | +$260K | ﹤0.01% | 2917 |
|
|
2013
Q4 | $1.06M | Buy |
8,628
+3,956
| +85% | +$482K | ﹤0.01% | 3332 |
|
|
2013
Q3 | $547K | Buy |
4,672
+1,725
| +59% | +$203K | ﹤0.01% | 4014 |
|
|
2013
Q2 | $330K | Buy |
+2,947
| New | +$346K | ﹤0.01% | 4695 |
|
Other funds holding BIO
VCM
VPM
AI
